Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 14 November 2018 (Status as of 1 January 2020)


Open article in different language:  DE  |  FR  |  IT
Art. 14 Reanalysis

If ready-to-use medi­cin­al products are man­u­fac­tured in a State with which Switzer­land has not signed an agree­ment on the mu­tu­al re­cog­ni­tion of the GMP con­trol pro­ced­ures and there are jus­ti­fied doubts about the safety or qual­ity of the batches to be im­por­ted, Swiss­med­ic may or­der that each batch un­der­go reana­lys­is in Switzer­land.

Previous article Show article in the law Next article

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Gesetzeskürzel Name
DE FR IT EN
DE FR IT EN
Laden